Stay updated on Elderly Breast Cancer: Pertuzumab Combo Clinical Trial
Sign up to get notified when there's something new on the Elderly Breast Cancer: Pertuzumab Combo Clinical Trial page.

Latest updates to the Elderly Breast Cancer: Pertuzumab Combo Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe record history now includes a new revision entry v3.3.4 and removes the previous entry v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe additions show Revision: v3.3.3, and deletions remove the HHS Vulnerability Disclosure and Revision: v3.3.2, which are minor maintenance updates affecting site navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check58 days agoChange DetectedThe Record History now includes a new revision entry (v3.3.2) and removes the older entry (v3.2.0), updating the history list without altering study content.SummaryDifference0.1%

- Check65 days agoChange DetectedThe top government funding/operating status notice was removed; the page’s study history and details remain the same.SummaryDifference0.6%

- Check87 days agoChange DetectedTwo screenshots indicate a minor UI/layout update to the Record History page, with the version history and study status data unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check108 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference12%

Stay in the know with updates to Elderly Breast Cancer: Pertuzumab Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elderly Breast Cancer: Pertuzumab Combo Clinical Trial page.